Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Hims & Hers Health Shares Climb After News of Double-Digit Revenue Growth. Is It Too Late to Buy the Stock?

TheMotleyFool

0 0

Hims & Hers Health Shares Climb After News of Double-Digit Revenue Growth. Is It Too Late to Buy the Stock?: https://g.foolcdn.com/editorial/images/776314/gettyimages-1368091527.jpg

Shares of Hims & Hers Health (NYSE: HIMS) jumped following the company's first-quarter earnings report that once again announced surging revenue growth. That performance has helped the stock perform well this year, up about 40%.

Let's look at some recent comments from the CEO that caused the stock to dip, the company's recent quarterly results, and whether it's too late to buy the stock.

Hims & Hers CEO Andrew Dudum caused some controversy ahead of the company's earnings report when he came out on social media in support of pro-Palestinian college protests, while saying his company would be willing to hire the protesters.

Source Fool.com

Like: 0

HIMS

Share